Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Recombinant Antibody

Anti-Human PTHrP/PTHLH (1-34) Antibody (SAA0327)

Catalog #:   RHC93102 Specific References (48) DATASHEET
Host species: Mouse
Isotype: IgG1, lambda
Applications: ELISA
Accession: P12272
Overview

Catalog No.

RHC93102

Species reactivity

Human

Host species

Mouse

Isotype

IgG1, lambda

Clonality

Monoclonal

Target

Parathyroid hormone-like protein, PTHrP, PTH-rP, Parathyroid hormone-related protein, PTHrP[107-139], PLP, PTHRP, PTHLH

Concentration

1.8 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

P12272

Applications

ELISA

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

SAA0327

Data Image
  • SEC-HPLC
    The purity of this product is >95% as determined by SEC-HPLC.
References

Efficacy and safety of abaloparatide, denosumab, teriparatide, oral bisphosphonates, and intravenous bisphosphonates in the treatment of male osteoporosis: a systematic review and Bayesian network meta-analysis., PMID:40309441

Selective modulation of the bone remodeling regulatory system through orthodontic tooth movement-a review., PMID:40115506

Refractory hypercalcemia caused by parathyroid-hormone-related peptide secretion from a metastatic pancreatic neuroendocrine tumor: a case report., PMID:39924477

Successful Treatment of Methotrexate-associated Lymphoproliferative Disorder with the Pola-R-CHP Regimen., PMID:39757000

Anti-PTHrP blockade limits CD8+ T-cell exhaustion in anti-cancer immunotherapy., PMID:39554058

Latest on Anabolic Agents for Osteoporosis Treatment., PMID:39448133

Receptor activity-modifying protein modulation of parathyroid hormone-1 receptor function and signaling., PMID:39376604

Shoring Up Osteoporosis Management: A Fresh Start?, PMID:39142871

Clinical effects of teriparatide, abaloparatide, and romosozumab in postmenopausal osteoporosis., PMID:39009890

Romosozumab versus parathyroid hormone receptor agonists: which osteoanabolic to choose and when?, PMID:38938063

Connexin hemichannels drive lactation-induced osteocyte acidification and perilacunar-canalicular remodeling., PMID:38935505

The use of anabolic agents in the treatment of osteoporosis: a clinical update., PMID:38752851

Cardiovascular Safety of Romosozumab vs PTH Analogues for Osteoporosis Treatment: A Propensity-Score-Matched Cohort Study., PMID:38482603

The pathophysiology of hypophosphatemia., PMID:38087658

Exploring dual effects of dinutuximab beta on cell death and proliferation of insulinoma., PMID:37802653

PTHrP Regulates Fatty Acid Metabolism via Novel lncRNA in Breast Cancer Initiation and Progression Models., PMID:37568579

Paraneoplastic autoimmune hypophysitis: a novel form of paraneoplastic endocrine syndrome., PMID:37045779

Markers for internal neoplasia in the horse., PMID:36495211

Antagonizing microRNA-19a/b augments PTH anabolic action and restores bone mass in osteoporosis in mice., PMID:36193848

Hypercalcemia in the setting of HTLV-1 infection and a normal PTHrP level., PMID:36137195

High Sensitivity Measurement of Parathyroid Hormone-Related Protein (PTHrP) in Plasma by LC-MS/MS., PMID:36127605

Immunoarray Measurements of Parathyroid Hormone-Related Peptides Combined with Other Biomarkers to Diagnose Aggressive Prostate Cancer., PMID:36074029

Involvement of Met receptor pathway in aggressive behavior of colorectal cancer cells induced by parathyroid hormone-related peptide., PMID:36051345

Parathyroid hormone-related protein (PTHrP) and malignancy., PMID:35953108

Parathyroid hormone-related peptide and parathyroid hormone-related peptide receptor type 1 in locally advanced laryngeal cancer as prognostic indicators of relapse and survival., PMID:35761298

Parathyroid Hormone-Related Protein Inhibition Blocks Triple-Negative Breast Cancer Expansion in Bone Through Epithelial to Mesenchymal Transition Reversal., PMID:35720668

Functional Properties of Two Distinct PTH1R Mutants Associated With Either Skeletal Defects or Pseudohypoparathyroidism., PMID:35720667

The role of osteoanabolic agents in the management of patients with osteoporosis., PMID:35635798

PTHrP induces STAT5 activation, secretory differentiation and accelerates mammary tumor development., PMID:35440032

Development of a PTHrP chemiluminescent immunoassay to assess humoral hypercalcemia of malignancy., PMID:35429486

Abaloparatide Improves Rotator Cuff Healing via Anabolic Effects on Bone Remodeling in a Chronic Rotator Cuff Tear Model of Rat With Osteoporosis: A Comparison With Denosumab., PMID:35404150

Anti-sclerostin antibodies and abaloparatide have additive effects when used as a countermeasure against disuse osteopenia in female rats., PMID:35398589

Anabolic Therapy for Osteoporosis., PMID:34313699

Pharmacological interventions versus placebo, no treatment or usual care for osteoporosis in people with chronic kidney disease stages 3-5D., PMID:34231877

[Endoscopic ultrasound-guided fine-needle biopsy for diagnosis of pancreatic metastases producing parathyroid hormone-related protein]., PMID:33967133

A Role for TGFβ Signaling in Preclinical Osteolytic Estrogen Receptor-Positive Breast Cancer Bone Metastases Progression., PMID:33923316

Calcitriol-mediated hypercalcemia as an immune-related adverse event in a patient receiving nivolumab and ipilimumab for metastatic renal cell carcinoma, case report., PMID:33794867

PTHrP Drives Pancreatic Cancer Growth and Metastasis and Reveals a New Therapeutic Vulnerability., PMID:33589425

Extracellular vesicles-released parathyroid hormone-related protein from Lewis lung carcinoma induces lipolysis and adipose tissue browning in cancer cachexia., PMID:33510128

Immune checkpoint inhibitor-associated hypercalcaemia., PMID:33374000

c-Met expression in renal cell carcinoma with bone metastases., PMID:33024658

High endogenous expression of parathyroid hormone-related protein (PTHrP) supports osteogenic differentiation in human dental follicle cells., PMID:32710187

Characterizing patients initiating abaloparatide, teriparatide, or denosumab in a real-world setting: a US linked claims and EMR database analysis., PMID:32696118

Effects of alcohol and nicotine consumption on the development of apical periodontitis in rats: a correlative micro-computed tomographic, histological and immunohistochemical study., PMID:32516436

MiR-132/212 promotes the growth of precartilaginous stem cells (PCSCs) by regulating Ihh/PTHrP signaling pathway., PMID:32319512

Pharmacological Therapy of Osteoporosis: What's New?, PMID:32273690

Immunoexpression of bone resorption biomarkers in apical periodontitis in diabetics and normoglycaemics., PMID:32271943

Parathyroid hormone receptor 1 (PTHR1) is a prognostic indicator in canine osteosarcoma., PMID:32005896

Datasheet
$ 372
Product specifications
100 μg 372 1 mg 1860

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-Human PTHrP/PTHLH (1-34) Antibody (SAA0327) [RHC93102]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only